Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling
Open Access
- 18 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 980539
Abstract
Strategies based on intracellular expression of artificial binding domains present several advantages over manipulating nucleic acid expression or the use of small molecule inhibitors. Intracellularly-functional nanobodies can be considered as promising macrodrugs to study key signaling pathways by interfering with protein-protein interactions. With the aim of studying the RAS-related small GTPase RHOA family, we previously isolated, from a synthetic phage display library, nanobodies selective towards the GTP-bound conformation of RHOA subfamily proteins that lack selectivity between the highly conserved RHOA-like and RAC subfamilies of GTPases. To identify RHOA/ROCK pathway inhibitory intracellular nanobodies, we implemented a stringent, subtractive phage display selection towards RHOA-GTP followed by a phenotypic screen based on F-actin fiber loss. Intracellular interaction and intracellular selectivity between RHOA and RAC1 proteins was demonstrated by adapting the sensitive intracellular protein-protein interaction reporter based on the tripartite split-GFP method. This strategy led us to identify a functional intracellular nanobody, hereafter named RH28, that does not cross-react with the close RAC subfamily and blocks/disrupts the RHOA/ROCK signaling pathway in several cell lines without further engineering or functionalization. We confirmed these results by showing, using SPR assays, the high specificity of the RH28 nanobody towards the GTP-bound conformation of RHOA subfamily GTPases. In the metastatic melanoma cell line WM266-4, RH28 expression triggered an elongated cellular phenotype associated with a loss of cellular contraction properties, demonstrating the efficient intracellular blocking of RHOA/B/C proteins downstream interactions without the need of manipulating endogenous gene expression. This work paves the way for future therapeutic strategies based on protein-protein interaction disruption with intracellular antibodies.Keywords
Funding Information
- Fondation pour la Recherche Médicale (FDT20130928310)
This publication has 62 references indexed in Scilit:
- A New Protein-Protein Interaction Sensor Based on Tripartite Split-GFP AssociationScientific Reports, 2013
- Nonpolarized signaling reveals two distinct modes of 3D cell migrationJournal of Cell Biology, 2012
- RhoA and RhoC have distinct roles in migration and invasion by acting through different targetsJournal of Cell Biology, 2011
- Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1Nature Cell Biology, 2010
- Selection of Genetically Encoded Fluorescent Single Domain Antibodies Engineered for Efficient Expression in Escherichia coliJournal of Biological Chemistry, 2007
- GTP‐binding proteins of the Rho/Rac family: regulation, effectors and functions in vivoBioEssays, 2007
- RhoA and ROCK Promote Migration by Limiting Membrane ProtrusionsJournal of Biological Chemistry, 2003
- Rho GTPases in cell biologyNature, 2002
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factorsCell, 1992